Pentobarbital will lower the extent or result of fosamprenavir by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor. pentobarbital will reduce the level or influence of alosetron by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unfamiliar. Caution when discontinuing CYP3A4 inducers which have been coadministered with hydrocodone; ... https://fordb109oet7.shoutmyblog.com/profile